Posted by John Deo
Allstate (NYSE:ALL) delivered a standout fourth quarter, surpassing Wall Street expectations and sending its s
Source: Two Blokes Trading
Posted by John Deo
Labcorp's strategic collaborations aim to enhance clinical trial diversity, potentially boosting its market o
Source: Two Blokes Trading
Posted by John Deo
Cigna has experienced a 5.01% gain over the past 30 days, indicating strong investor confidence. The com
Source: Two Blokes Trading
Posted by John Deo
The average price target for Patrick Industries, Inc. (NASDAQ:PATK) has been adjusted from $131.43 to $105, r
Source: Two Blokes Trading
Posted by John Deo
Analysts have set an average price target of $166 for Expedia, with Citigroup being more optimistic at $200.
Source: Two Blokes Trading
Posted by John Deo
Bombardier Inc. Quarterly Earnings Preview and Financial Analysis Bombardier Inc., trading under the symbol
Source: Two Blokes Trading
Posted by John Deo
Linde plc (NASDAQ:LIN) reported an EPS of $3.97, beating the estimated $3.94 and showing an 11% increase in a
Source: Two Blokes Trading
Posted by John Deo
Expedia Group, Inc. (NASDAQ:EXPE) is expected to release its quarterly earnings on February 6, 2025, with an
Source: Two Blokes Trading
Posted by John Deo
Merck's adjusted earnings per share (EPS) of $1.72 surpassed the Zacks Consensus Estimate, indicating strong
Source: Two Blokes Trading
Posted by John Deo
Earnings Per Share (EPS) of $0.03, surpassing the estimated $0.02, indicating the company's ability to exceed
Source: Two Blokes Trading
Posted by John Deo
AstraZeneca (NASDAQ:AZN) is set to release its quarterly earnings with an estimated EPS of $1.10 and projecte
Source: Two Blokes Trading
Posted by John Deo
Earnings per share (EPS) of $0.91, slightly missing estimates but showing a significant year-over-year increa
Source: Two Blokes Trading